Antibodies to Human T-cell Lymphotropic Virus Type I (HTLV-I) by Particle Agglutination (PA) Test in Korean Blood Donors

Yonsei Medical Journal

Volumn 40, Issue 2, 1999, Pages 173-177

  Kim, June Myung ^a,c   Song, Young Goo ^a   Oho, Young Chul ^b   Park, Hyeong Cheon ^a   Kwon, Kun Ho ^a   Kim, Eung ^a   Lee, Seon Ho ^b   Kim, Ki Hong ^b  

^a Yonsei University   (South Korea)

^b Korean Red Cross   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Antibodies; HTLV I; Korea; Particle agglutination test

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGGLUTINATION TEST; ARTICLE; BLOOD; BLOOD DONOR; CHILD; FEMALE; HUMAN; KOREA; MALE; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGGLUTINATION TESTS; BLOOD DONORS; CHILD; FEMALE; HTLV-I ANTIBODIES; HUMANS; KOREA; MALE; SEX DISTRIBUTION;

EID: 0033113212     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1999.40.2.173     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention and the U.S.P.H.S Working Group. Guidelines for counselling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Ann Intern Med 1993; 118:448-54.
2. Clark JW, Robert-Guroff M, Ikehara O, Henzan E, Blattner WA. Human T-cell leukemia-lymphoma virus type 1 and adult T-cell leukemia-lymphoma virus in Okinawa. Cancer Res 1985;45:2849-52.
3. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, et al. Adult T-cell leukemia associated antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Nad Acad Sci USA 1981;78:6476-80.
4. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9.
5. Spalton DJ, Nicholson F. HTLV-I infection in human disease. Br J Ophthalmol 1991;75:174-5.
6. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-cell lymphotropic virus type-I in patients with tropical spastic paralysis. Lancet 1985;11:407-9.
7. Sarma PS, Gruber J. Human T-cell lymphotropic viruses in human diseases. J Natl Cancer Inst 1990;82:1100-6.
8. Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nationwide seroepidemiologic study. Int J Cancer 1982;29:631-5.
9. Kazunari Y. Human T-lymphotropic virus type I in Japan. Lancet 1994;343:213-6.
10. Marsh BJ. Infectious complications of human T cell leukemia/lymphoma virus type I infection. Clin Infect Dis 1996;23:138-45.
11. Shimoyama M, Minato K, Tobinai K, Horikoshi N, Ibuka T, Deura K, et al. Anti-ATLA (Antibody to the adult T-cell leukemia cell-associated antigen)-positive hematologic malignancies in the Kanto districts. Jpn J Clin Oncol 1982;12:109-16.
12. Tajima K, Tominaga S, Kuroishi T, Shimizu H, Suchi T. Geographical features and epidemiological approach to endemic T-cell leukemia/lymphoma in Japan. Jpn J Clin Oncol 1979;9 Suppl:495-504.
13. Blattner WA, Kalyanaraman VS, Robert-Guroff M, Lister TA, Galton DAG, Sarin PS, et al. The human type C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia /lymphoma. Int J Cancer 1982;30:257-64.
14. Fleming AF, Yamamoto N, Bhusnurmath SR, Maharajan R. Antibodies to ATLV (HTLV) in Nigerian blood donors and patients with chronic lymphatic leukemia or lymphoma. Lancet 1983;2:334-5.
15. Saxinger W, Blattner WA, Levine PH, Clark J, Biggar R, Hoh M, et al. Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science 1984;225:1473-6.
16. Pan IH, Chung CS, Komoda H, Imai J, Hinuma Y. Seroepidemiology of adult T-cell leukemia virus in Taiwan. Jpn J Cancer Res 1985;76:9-11.
17. Zeng Y, Lan XY, Fang J, Wang PZ, Wang YR, Sui YF, et al. HTLV antibody in China. Lancet 1984;i:799-800.
18. Hinuma Y, Chosa T, Komoda H, Mori I, Suzuki M, Tajima K, et al. Sporadic retrovirus (ATLV)-seropositive individuals outside Japan. Lancet 1983;i:824-5.
19. Lee YY, Lee HB, Seo CW, Kye KC, Kim ES, Park SY, et al. Seroepidemiology of Human T-cell leukemia virus type-I in the Republic of Korea. Korean J Med 1986; 31:141-7.
20. Lee MH, Kim BK, Lee HB, Park KS, Suh CW, Lee JH, et al. Adult T-cell leukemia-The first case in Republic of Korea. J Korean Med Assoc 1987;30:1146-52.
21. Park JH, Park SC, Suk SH, Kim WJ, Jung JW, Lee BI. A case of human T lymphotropic virus type I associated myelopathy (HAM). Korean J Neurol 1990;8:378-83.
22. Koprowski H, DeFreitas EC, Harper ME, Sandberg-Wollheim M, Sheremata WA, Robert-Guroff M, et al. Multiple sclerosis and human T-cell lymphotropic retrovirus. Nature 1985;318:154-60.
23. Greaves MF, Galton DAG, McCluskey DR, Lampert I, Ireland R, Bridges JM, et al. Adult T-cell lymphoma-leukemia in Blacks from the West Indies. Lancet 1982; 2:639-43.
24. Larkin J, Sinnott JT, Weiss J, Holt DA. Human T-cell lymphotropic virus type I. Infect Control Hosp Epidemiol 1990;11:314-8.
25. Pan XZ, Qiu ZD, Chein N, Gold JWM, Hardy D, Zuckerman E Jr., et al. A seroepidemiological survey of HTLV-I infection in Shanghai and Chongqing cities in China. AIDS 1991;5:782-3.
26. Seyfert S, Blum S. HTLV-I-associated myelopathy in China; A disease acquired overseas? J Neurol 1994;241: 398-400.
27. Takezaki T, Tajima K, Komoda H, Imai J. Incidence of human T lymphotropic virus type I seroconversion after 40 among Japanese residents in an area where the virus is endemic. J Infect Dis 1995;171:559-65.
28. The HTLV European Research Network. Seroepidemiology of the human T-cell leukemia/lymphoma viruses in Europe. J AIDS Hum Retrovirol 1996;13:68-77.
29. Chadburn A, Athan E, Wieczorek R, Knowles DM. Detection and characterization of human T-cell lymphotropic virus type I (HTLV-I) associated T-cell neoplasm in an HTLV-I nonendemic region by polymerase chain reaction. Blood 1991;77:2419-30.
30. Inaba S, Sato H, Okochi K, Fukada K, Takakura F, Tokunaga K, et al. Prevention of transmission of human T-lymphotropic virus type I (HTLV-I) through transfusion, by donor screening with antibody to the virus; One-year experience. Transfusion 1989;29:7-11.
31. Kline RL, Brothers T, Halsey N, Boulos R, Lairmore MD, Quinn TC. Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II. Lancet 1991;337:30-3.
32. Kobayashi S, Yoshida T, Hiroshige Y, Matsui T, Yamamoto N. Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors. J Clin Microbiol 1988; 26:308-12.